Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
The Journal of Infectious Diseases
|
January 12, 2017
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
Frederick G Hayden, Martin Friede, Daniel G Bausch
Bulletin of the World Health Organization
|
March 3, 2017
Therapeutic antibodies for infectious diseases
Erin Sparrow, Martin Friede, Mohamud Sheikh, et al.
Vaccine
|
December 20, 2017
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance
Tania Cernuschi, Stefano Malvolti, Emily Nickels, et al.
Vaccine
|
October 19, 2019
Meeting report: Global vaccine and immunization research forum, 2018
Peter Dull, Martin Friede, Angela Hwang, et al.
Vaccine
|
February 15, 2026
Pathways to economically viable and sustainable vaccine manufacturing in LMICs
Matthias Helble, Claudia Nannei, Martin Friede, et al.
Vaccine
|
July 9, 2022
Technology transfer programme for influenza vaccines - Lessons from the past to inform the future
Christopher Chadwick, Martin Friede, Ann Moen, et al.
Trends in Immunology
|
December 9, 2008
New horizons in adjuvants for vaccine development
Steven G Reed, Sylvie Bertholet, Rhea N Coler, et al.
Vaccine
|
September 14, 2016
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
Erin Sparrow, Martin Friede, Mohamud Sheikh, et al.
Vaccine
|
October 19, 2006
A review of human vaccine research and development: malaria
Marc P Girard, Zarifah H Reed, Martin Friede, et al.
BMJ (Clinical Research Ed.)
|
November 12, 2016
Developing a vaccine against Zika
Joachim Hombach, Martin Friede, Vasee Moorthy, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
The Journal of Infectious Diseases
|
January 12, 2017
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
Frederick G Hayden, Martin Friede, Daniel G Bausch
Bulletin of the World Health Organization
|
March 3, 2017
Therapeutic antibodies for infectious diseases
Erin Sparrow, Martin Friede, Mohamud Sheikh, et al.
Vaccine
|
December 20, 2017
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance
Tania Cernuschi, Stefano Malvolti, Emily Nickels, et al.
Vaccine
|
October 19, 2019
Meeting report: Global vaccine and immunization research forum, 2018
Peter Dull, Martin Friede, Angela Hwang, et al.
Vaccine
|
February 15, 2026
Pathways to economically viable and sustainable vaccine manufacturing in LMICs
Matthias Helble, Claudia Nannei, Martin Friede, et al.
Vaccine
|
July 9, 2022
Technology transfer programme for influenza vaccines - Lessons from the past to inform the future
Christopher Chadwick, Martin Friede, Ann Moen, et al.
Trends in Immunology
|
December 9, 2008
New horizons in adjuvants for vaccine development
Steven G Reed, Sylvie Bertholet, Rhea N Coler, et al.
Vaccine
|
September 14, 2016
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
Erin Sparrow, Martin Friede, Mohamud Sheikh, et al.
Vaccine
|
October 19, 2006
A review of human vaccine research and development: malaria
Marc P Girard, Zarifah H Reed, Martin Friede, et al.
BMJ (Clinical Research Ed.)
|
November 12, 2016
Developing a vaccine against Zika
Joachim Hombach, Martin Friede, Vasee Moorthy, et al.
Page
of 4